GLP1R and type 2 diabetes mellitus: In the present work, higher levels of MCACs and LCACs in individuals with T2D may reflect subclinical metabolic inflexibility and inefficient mitochondrial fatty acid oxidation but are modifiable by GLP-1 RA therapy.